UNSPSC 51142038: Bicifadine hydrochloride

This classification denotes a neuroprotective agent with the molecular formula C12H15N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OE6G20P68T, chemically known as 3-azabicyclo(3.1.0)hexane, 1-(4-methylphenyl)-, hydrochloride, (+-)- but more generally known as bicifadine hydrochloride, which bears US NIH Compound Identifier 47952. European Medicines Agency schedules Bicifadine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32896.

Most nations, for tariff and trade purposes, schedule bicifadine hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, BICIFADINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Bicifadine hydrochloride bears US NLM identifiers UMLS ID C0106275 and NCI Concept Code C81047. SMILES: CC1CCC(CC1)[C@@]23C[C@@H]2CNC3.CL.

UNSPSC 51142038 Bicifadine hydrochloride is a Commodity code that nominal sources describe as a specific pharmaceutical compound, yet recent state and local opportunities posted under this code show virtually no activity aligned with bicifadine procurement. The three most recent opportunities — a Seminole County, Florida naloxone and drug deactivation systems IFB; a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs; and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products — address naloxone supply, pharmacy benefit program architecture, and generics procurement respectively, none of which concern bicifadine specifically. State and local procurement offices appear to use this code inconsistently or as a placeholder within broader pharmaceutical procurement categories rather than as a dedicated vehicle for bicifadine acquisition.

The geographic spread of these opportunities spans Florida, Texas, and Minnesota, reflecting ad-hoc activity across dispersed jurisdictions and multi-state cooperative purchasing vehicles rather than concentrated demand. Issuing bodies include county health departments (Seminole County), state health and human services agencies (Texas HHS Commission), and cooperative purchasing alliances serving multiple states and municipalities (MMCAP, administered by the Minnesota Department of Administration). The lack of bicifadine-specific solicitations and the mismatch between the code's nominal scope and the actual work being bought suggest this code sees little relevant recent activity for vendors focused on bicifadine supply or any specialized pharmaceutical product line.